Onxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications

Press/Media

Period28 May 2015

Media coverage

28

Media coverage

  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletCNBC
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletBusiness Wire
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletNASDAQ OMX
    CountrySweden
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletPharmiWeb
    CountryUnited Kingdom
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletFranklin Credit Management Corporation
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletTown Hall
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletFat Pitch Financials
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletMoneyShow.com
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletMarketplace
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletBioSpace
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletRCL Advisors
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletIndustrial Info Financials
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletMarket Pulse Navigator
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletSearchBug
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletWall Street Business Network
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletReliance Trust
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletCEOWorld Magazine
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletCrawford Financial Planning
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletYahoo! UK and Ireland
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletTamar Securities
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orpha
    Media name/outletQuoteline
    CountrySwitzerland
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletGreen Technology
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletI Stock Analyst
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletMyrtle Beach Sun News
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletAsk.com
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletGood Day Sacramento
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletFinanzNachrichten.de
    CountryGermany
    Date28/05/15
    PersonsMauricio Burotto
  • TitleOnxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
    Media name/outletGlobeNewswire
    CountryUnited States
    Date28/05/15
    PersonsMauricio Burotto